In quest of tomorrow's medicines

An eminent scientist discusses the pharmaceutical industry, biotechnology, and the future of drug research. In our fast-paced, tech-driven lives, we often rely on various medications for minor health issues, as well as for serious diseases, where they serve as vital tools for physicians, saving or prolonging lives. Despite their significance, many remain unaware of how these medicines are developed. Jurgen Drews, a prominent figure in the pharmaceutical sector, shares insights from his experience leading international research teams at Hoffman-LaRoche. He chronicles the evolution of drug development from early pharmacies and chemical companies in Switzerland, Germany, and the U.S. to the large corporations dominating Europe, Japan, and America today. Drews explains the drug testing process and the impact of AIDS activism on approval processes in the U.S. His commentary on clinical trials highlights the complexities and costs involved in bringing innovations to market. In the concluding chapters, he critically analyzes pharmaceutical research, identifying effective strategies and management practices that hinder progress. Drews also examines the implications of the growing relationship between biotechnology and academic research for the pharmaceutical industry, making his insights essential for researchers, managers, and investors. Written in accessible language, this work is aimed at professionals in the pharmaceutical and bio